SCHEMBL24623618

SCHEMBL24623618

c1cnc2c(c1)oc1cnncc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ HSP90AA1 P07900 4/20 0.38
▸ L3MBTL1 Q9Y468 4/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ KDM4E B2RXH2 7/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 5/20 0.37
▸ LMNA P02545 3/20 0.37
▸ CCR1 P32246 3/20 0.37
▸ CCR8 P51685 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ GMNN O75496 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11884998 0.81 TDO2 (0.42) MEN1KMT2AHSP90AA1L3MBTL1NPC1
SCHEMBL6925972 0.80 KDM4E (0.48) MEN1KMT2AHSP90AA1L3MBTL1NPC1
SCHEMBL148991 0.79 KMT2A (0.58) MEN1KMT2AHSP90AA1L3MBTL1NPC1
SCHEMBL29625837 0.79 KMT2A (0.58) MEN1KMT2AHSP90AA1L3MBTL1NPC1
SCHEMBL27174137 0.79 KMT2A (0.58) MEN1KMT2AHSP90AA1L3MBTL1NPC1
SCHEMBL11885009 0.78 MAPK14 (0.42) MEN1KMT2AHSP90AA1L3MBTL1NPC1
Triphenylene SCHEMBL29177920 0.78 KMT2A (0.56) MEN1KMT2AHSP90AA1L3MBTL1NPC1
SCHEMBL20005635 0.77 KMT2A (0.50) MEN1KMT2AHSP90AA1L3MBTL1NPC1
SCHEMBL22373940 0.77 CCR1 (0.41) MEN1KMT2AHSP90AA1L3MBTL1NPC1
SCHEMBL24624526 0.74 KDM4E (0.51) MEN1KMT2AHSP90AA1L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF Wuhan Tianma Microelectronics Co., Ltd. Shanghai Branch (CN) 2022-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF NR0B2, FPR3, NPR3 MEN1 1937/4885KMT2A 3303/4885HSP90AA1 4200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback